|
Real-time Estimate
Cboe BZX
23:59:51 14/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 19.61 USD | +0.82% |
|
+6.52% | +7.46% |
| 08-06 | Avalo Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 07-18 | Avalo Therapeutics Says Some Shareholders May Sell Up to 128,189 Shares | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AVALO THERAPEUTICS, INC. | Bio Therapeutic Drugs | +0.21% | +6.52% | +7.46% | +118.04% | -99.76% | 1.04B |  | | |
- Stock Market
- Stocks
- AVTX Stock
- Charts Avalo Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
